Hapvida Participações e Investimentos S.A. — Cyborg Score 6/10
Solid
Supplementary Health Insurance / Healthcare Services (Brazil)
Strategic Profile
Hapvida operates in the supplementary health sector with a verticalized business model where care for beneficiaries is primarily provided through its own network, aiming to offer quality and low-cost medical and dental care. The transformative 2022 business combination with Notre Dame Intermédica, valued at $8.9 billion, solidified its position as Brazil's largest healthcare plan company.
Cyborg Score Rationale
Hapvida demonstrates solid market fundamentals as Brazil's largest healthcare operator with strong scale and vertical integration. However, integration challenges from the Notre Dame merger and governance concerns (ISS score of 6) temper growth momentum. The company shows operational scale advantage but faces execution risks.
Top Insights
The verticalized and integrated business model is a significant differentiator, with integrated management focused on customer needs aligned with international standards and technology used for cost control and quality improvement.
Hapvida serves over 15 million beneficiaries as of Q1 2025, representing significant market penetration in Brazil's supplementary health sector.
The company reported an 8.2% increase in average ticket between 2Q24 and 2Q25, with a 7.2% increase in net price mainly from readjustments.
ISS Governance QualityScore is 6, with weaker shareholder rights (score: 1) relative to strong compensation controls (score: 10), indicating governance tensions.
Named Competitors
Health Insurance Plans — National network of cooperative health insurance providers
Health Insurance Plans — Major health insurance operator with network model
Health Insurance Plans — Large supplementary health operator in Brazil
Recent Developments
(November 2022) Completed business combination with Notre Dame Intermédica (GNDI merger), consolidating position as Brazil's largest healthcare plan operator
(2022) Acquired Smile Group health plan operator with ~80,000 beneficiaries in Northeast and Central-West regions
(2024-2025) Implemented 8.2% average ticket growth with 7.2% net price increases through portfolio readjustments
Open the full interactive Hapvida Participações e Investimentos S.A. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.